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Background: Independent audits have been proposed to improve carotid endarterectomy (CEA) effectiveness. This study
used the online registry Modification of Outcomes by Lowering Ischemic Events after Reconstruction of Extracranial
Vessels (MOLIERE) to evaluate the effectiveness of CEA in the Province of Quebec. The concept of MOLIERE is that
surgeon involvement in a prospective manner is a prerequisite for them to evaluate, compare, and improve their practice.
Methods: All Quebec surgeons who performed CEA were invited to participate in this study sponsored by the Société des
sciences vasculaires du Québec, the Canadian Society for Vascular Surgery and the Association des chirurgiens vasculaires
du Québec. Surgeons prospectively entered data for 60 variables relevant to CEA in an online, secure, and confidential
database between May 24, 2004, and May 31, 2005. Patient inclusion had to occur before surgery. After the study was
completed, charts of all CEAs performed in each participating center were reviewed to validate the results of MOLIERE.
For each participating institution, results of CEA that were not entered in the registry were also reviewed.
Results:A total of 279 patients (mean age, 69 years; range, 46-91 years) undergoing a CEA were enrolled in MOLIERE by 23
surgeons from 10 institutions in Quebec; 157 (56%) were symptomatic, and 122 (44%) were asymptomatic. Carotid
endarterectomies were performed with patch angioplasty in 252 (89%), primary closure in 24 (9%), and by eversion in six (2%).
Follow-up at 30 days was achieved for all patients. The 30-day stroke or death rates for symptomatic and asymptomatic
patients were 3.2% (5 of 157, 95% confidence interval [CI], 1.2%-7.4%) and 0%. Validation was excellent for patients who were
entered in the registry, with no additional deaths or strokes than those reported by the surgeons. The validation process
revealed that participating surgeons entered 66% (279 of 424) of their patients in the registry. Indications and stroke or
death rates (SDRs) for those patients who were not entered in the registry were not statistically different (symptomatic,
54% [79 of 145]; SDR of 1.3% [1 of 76] for symptomatic and 1.5% [1 of 66] for asymptomatic). In participating
institutions, 11 surgeons did not participate. The SDRs for patients operated on by nonparticipating surgeons were
higher but not statistically different than rates for patients operated on by participating surgeons (3.7% [5 of 136] vs 1.7%
[7 of 424], P  .16). There was a trend toward higher stroke rate for patients operated on by nonparticipating surgeons
(3.7% [5 of 136] vs 1.2% [5 of 424], P  .056). Mean postoperative length of stay was statistically higher for patients
operated on by nonparticipating surgeons (4.7 vs 3.4 days, P  .046). The SDRs were adequate for all surgeons in
participating centers, with 95% CI within accepted standards for symptomatic and asymptomatic patients.
Conclusion: MOLIERE is the first Canadian online prospective registry allowing surgeons to audit CEA results. The
SDRs for participating surgeons were valid and within standards. Scientific vascular societies played a key role in
supporting this project. Such audits allow surgeons and medical stroke experts to examine the appropriateness and results
of CEAs in their institutions to improve them. The future of MOLIERE is in validation of its concept, increased
participation by surgeons, and integration of a multidisciplinary approach. (J Vasc Surg 2008;47:530-6.)From the Service de chirurgie vasculaire, Centre de santé et de services
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propriateness as performed in four Western Canadian prov-
inces between January 2000 and December 2001. Only
half (52.3%) of the CEAs met their criteria for appropriate-
ness, and CEA for “inappropriate” reasons occurred at an
overall rate of 10.3%. Tu et al,5 in a retrospective analysis of
CEA complication rates in 6000 patients operated on in
34 hospitals in Ontario, reported a 4.7% rate of stroke or
death in asymptomatic patients. On the basis of the results,
the authors appropriately questioned whether these asymp-
tomatic patients were receiving the benefit of CEA reported
in the Asymptomatic Carotid Atherosclerosis Study
(ACAS) trial, where the 30-day stroke and death rate
(SDR) was 2.3%. As for any other prophylactic treatments,
concerns about the appropriateness and risk of CEA and
carotid stenting are more real than ever. How can we
ensure that patients are offered CEAs at acceptable risk and
for appropriate indications?6
The Modification of Outcomes by Lowering Isch-
emic Events after Reconstruction of Extracranial Vessels
(MOLIERE) prospective observational study is designed
to address several current controversies by allowing all
surgeons in the province of Quebec to enroll their own
patients undergoing CEA, in an innovative online database.
The concept behind MOLIERE is that surgeon and neu-
rologist involvement in a prospective manner is a prerequi-
site for them to evaluate, compare, and improve their
practice. Therefore, the objectives of our study were to:
1. demonstrate the feasibility of an innovative, online,
prospective registry,
2. evaluate the indications and results of CEAs in partici-
pating institutions, and
3. validate this auditing tool.
METHODS
Participating institutions. We used the Med-Echo
administrative database to identify 28 institutions where at
least one CEA had been performed in Quebec. Surgeons of
these institutions were invited to participate in MOLIERE,
and the involvement of neurologists was suggested. A
protocol reviewed by a research committee composed of
members of the Quebec Vascular Society (Association des
chirurgiens vasculaires du Québec) and La Société des
sciences vasculaires du Québec (SSVQ) was sent to the
surgeons.
To participate in the study, the protocol had to be
approved by the Research Ethics Board of the surgeons’
hospital. The protocol clearly stated that two independent
reviewers would have access to the charts of all the CEA
patients operated on that year in the participating institu-
tion. Surgeons had to obtain signed informed consent from
each patient enrolled stating their agreement that their
personal information concerning the CEA would be avail-
able on a secure Web-based database.
The protocol also stated that all participating surgeons
would receive their personal results in a confidential matter.
This would subsequently promote positive criticism amongthe group of surgeons in each respective hospital. Partici-
pating surgeons, defined as surgeons who enrolled at least
one patient in the database, were encouraged to include all
their patients in the registry.
Web-based database. An Internet database available
to surgeons 24 hours a day, 7 days a week was established
with the help of Gestion recherche clinique Québec
(GEREQ), a government-funded agency that promotes
clinical research through online databases and provides
investigators with an integrated electronic data manage-
ment and E-learning platform. GEREQ’s systems and ser-
vices are in compliance with international regulations and
guidelines, including the International Conference onHar-
monisation, the United States Food and Drug Adminis-
tration, Health Canada, and the European Agency for
the Evaluation of Medicinal Products. The database for
MOLIERE contained 60 variables relevant to CEA,
which were divided into four categories:
● Identification and preoperative assessment addressed
the issue of appropriateness, with variables such as
CEA indication, risk factors for stroke, degree of ste-
nosis, and preoperative investigations. Symptomatic
patients were defined as those having ipsilateral hemi-
spheric symptoms or amaurosis fugax 6 months.
● The hospitalization section evaluated information
about hospital stay and technical aspects of the proce-
dure as well as the use of medications.
● The postoperative assessment section included variables
related to perioperative complications such as death,
stroke, transient ischemic attack, cervical hematoma,
cardiac complications, and reoperation. All new defi-
cits lasting 24 hours were considered a stroke. No
attempt was made to distinguish major or disabling
strokes fromminor events. Information about postop-
erative brain imaging, cranial nerve damage, and dys-
phagia was also requested.
For ease of use, the variables were presented to sur-
geons as an online survey. To maintain restricted access to
the database, each surgeon was assigned a unique login
name and password selected by GEREQ. An information
session was held at the 2004 Entretiens Vasculaires meeting
by GEREQ to teach surgeons how to use the Web site. To
ensure the prospective nature of our study and to limit bias,
patient registration had to be completed before surgery.
Demographic data and information pertaining to the sur-
gery itself or hospitalization could be completed at the
surgeons’ discretion at any time after patient registration,
but data could not be confirmed in the databank before 30
days to ensure the registration of all 30-day complications
during the follow-up period. Patient enrollment started on
May 24, 2004 and ended on May 31, 2005, inclusively,
with database closure on December 31, 2005.
Validation. We retrospectively identified all charts of
patients treated by CEA during the study period in partic-
ipating institutions. Patients operated on by participating as
well as nonparticipating surgeons were reviewed. The pro-
portions of patients not included in the study by participat-
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nonparticipating surgeons in participating institutions were
verified. Charts were reviewed by two independent research
assistants blinded to the MOLIERE database. Validation
included data about demographics and complications such
as stroke, death, cardiac complications, readmission, and
reintervention.
The auditors had access to patient hospital files in July
and August 2006, which was a year after the last patient was
registered for the study. By this means, the auditors had
access to the outpatient files and any external clinical visit to
validate follow-up data at 30 days. For comparison, Med-
Echo also provided the number of cases in each hospital
during the study period.
Statistical analyses. Descriptive statistics were re-
corded. Continuous data are presented as means  stan-
dard deviation, and dichotomous data, as percentages. The
Student and Pearson 2 tests were applied for univariate
analysis, and logistic regression for multivariate analysis.
The modified Wald method was used to calculate the 95%
confidence intervals (CI) All values of P  .05 were con-
sidered statistically significant.
RESULTS
Participation and feasibility. Carotid endarterecto-
mies were performed by 34 surgeons in the 10 participating
centers, two academic centers, and eight community hos-
pitals. The 23 surgeons who entered at least one CEA
patient in MOLIERE database were defined as participat-
ing surgeons. The 11 surgeons working in those 10 centers
who did not enter any patients were defined as nonpartici-
pating surgeons. All but one of the surgeons who decided to
participate were vascular surgeons. The remaining surgeons
performing CEA in Quebec in 18 nonparticipating centers
refused to participate in MOLIERE. Data from these cen-
ters were not available, but according to the Med-Echo
administrative database, 636CEAs were performed in these
centers during MOLIERE, and six of the 18 centers had a
volume of less than six CEAs. The reasons invoked by those
18 centers for not participating are reported in Table I.
During the study, 560 patients had CEA performed in
participating institutions, which was 47% of the 1196 CEAs
performed in Quebec during MOLIERE. The Web-based
registry was easily accessed by surgeons with data entry time
of2 minutes for most cases. Carotid endarterectomy was
done in 279 of the 294 patients entered in the registry. The
other 15 patients were 5 duplicates, and 10 were not
operated on for various reasons, including no indication, 4;
waiting list, 2; and 1 patient each because of refusal, death
metastatic cancer, and myocardial infarction. All 279 CEA
patients were followed up for 30 days. Despite having CEA
in participating institutions, 281 patients were not enrolled
in MOLIERE; of whom 145 were not enrolled by partici-
pating surgeon for various reasons that were not systemat-
ically recorded, and 136 patients were not enrolled in the
database by 11 nonparticipating surgeons. Participating
surgeons enrolled 66% (279 of 424) of their patients un-dergoing CEA in MOLIERE, with an inclusion rate vary-
ing from 6% to 100% per participating surgeon.
Indications. Before CEA, 44% of the 279 patients
(32%women) enrolled were asymptomatic. Their mean age
was 69 years (range, 46-91 years). Of the 157 patients
(56%) who had a symptomatic stenosis, 48 (31%) had
amaurosis, 59 (38%) had a transient ischemic attack, and 50
(32%) had a stroke. Patient comorbidities, imaging studies,
medication, and operative details are reported in Table II.
All patients enrolled were operated on under general anes-
thesia, 70% had a shunt, and 89% had a CEA with a patch
angioplasty.
Results and validation. The overall SDR at 30 days
for patients enrolled in MOLIERE was 1.8% (5 of 279),
consisting of 3.2% for symptomatic patients (5 of 157) and
0% for asymptomatic patients (0 of 122), and the in-
hospital cardiac complication rate was 5.7% (16 of 279).
The average postoperative length of stay was 3.0 days
(median, 2.0 days), and 13 patients were readmitted 30
days. Two patients presented with dysphagia, but no nerve
injuries were reported. Detailed complications rates are
reported in Table III. For patients who were enrolled in
MOLIERE, validation after independent review of all
charts was excellent, with no additional deaths or strokes
than those reported by the surgeons.
Results of CEA in participating institutions are re-
ported in Tables IV and V and in Figs 1 and 2. For patients
operated on by participating surgeons, SDRs were not
higher or statistically different for those patients not en-
rolled in MOLIERE compared with those enrolled in
MOLIERE. The SDRs for patients operated on by nonpar-
ticipating surgeons were higher but not statistically differ-
ent than the SDRs for patients operated on by participating
Table I. Reasons stated for accepting or refusing to
participate in the MOLIERE study
Reasons given by surgeons for not participating
1. Lack of time
2. Lack of interest
3. Difficulty with REB:
● Too many steps to obtain approval
● No REB available in one community hospital, so approval
from the principal investigator’s center was obtained.
● The REB in one academic center rejected the project for
lack of scientific background supporting sharing of confi-
dential information on the Internet
4. No longer performing CEA
5. Awaiting new duplex scan in the operating room
6. First year in practice
Reasons given by surgeons for participating
1. Ease of participation
2. Enthusiasm about sharing information with other surgeons
3. Eagerness to obtain documentation that could be presented
to their hospital CMDP
CEA, Carotid endarterectomy; CMDP, Conseil des médecins, dentistes et
pharmaciens; MOLIERE, Modification of Outcomes by Lowering Ischemic
Events after Reconstruction of Extracranial Vessels; REB, Research Ethics
Board.surgeons (3.7% [5 of 136] vs 1.7% [7 of 424], P  .16).
ion of
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 3 Nault et al 533There was a trend toward a higher stroke rate for patients
operated on by nonparticipating surgeons (3.7% [5 of 136]
vs 1.2% [5 of 424], P  .056). Also, the stroke rate was
Table II. Percentage of preoperative and perioperative ch
Characteristics All (N  279) Symptomati
Pre-op risk factors
Age, years
80, % 11
70-79, % 38
60-69, % 33
40-59, % 19
Mean  SD 6
CAD, % 53
Hypertension, % 76
Smoking, % 37
Diabetes, %
Type 1 6
Type II 23
Hyperlipidemia, % 74
Pre-op tests
Angiography, % 36
Doppler US imaging, % 99
MRI, % 7
CT scan, % 41
Pre-op and peri-op drugs, %
Antiplateletsa 96
Statins 79
-blockers 54
ACE inhibitors 51
Peri-op characteristics, %
CABG 0.4
General anesthesia 100
Shunt 70
Patch 89
ACE, Angiotensin-converting enzyme; CABG, coronary artery bypass g
Modification of Outcomes by Lowering Ischemic Events after Reconstruct
aPlavix (Sanofi-Aventis, Bridgewater, NJ) or aspirin, or both.
Table III. Thirty-day complication rates and length of
stay for patients enrolled in MOLIERE
Complication
All, No.
(%)
Symptomatic,
No. (%)
Asymptomatic,
No. (%)
Total 279 (100) 157 (100) 122 (100)
Stroke or death rate 5 (1.8) 5 (3.2) 0 (0)
Stroke rate 4 (1.4) 4 (2.5) 0 (0)
Mortality rate 2 (0.7) 2 (1.3) 0 (0)
Cardiac complications
rate 16 (5.7) 6 (3.2) 10 (8.2)
Acute coronary
syndrome 7 (2.5) 3 (1.9) 4 (3.3)
Pulmonary edema 3 (1.1) 0 (0) 3 (2.5)
Arrhythmia 8 (2.9) 3 (1.9) 5 (4.1)
Reintervention 1 (0.4) 1 (0.6) 0 (0)
Intubation 3 (1.1) 3 (1.9) 0 (0)
Hypoglossal injury 0 (0) 0 (0)
Post-op length of stay
Mean, days 3.0 3.4 2.6
Median, days 2.0 2.0 2.0
MOLIERE, Modification of Outcomes by Lowering Ischemic Events after
Reconstruction of Extracranial Vessels.significantly higher for asymptomatic patients operated onby nonparticipating surgeons (2.6% [1 of 39] vs 0% [0 of
188], P  .03). As depicted in Fig 2, all participating
centers had SDRs within accepted standards. The SDRs per
surgeon for symptomatic and asymptomatic patients were
all within standards.
The postoperative length of stay was significantly
longer for patients operated on by nonparticipating sur-
eristics among patients enrolled in the MOLIERE study
157, 56%) Asymptomatic (n  122, 44%) P
4
40
39
17
0 68  8 NS
55 NS (0.625)
76 NS (0.259)
32 NS (0.555)
4 NS (0.432)
24 NS (0.773)
71 NS (0.115)
39 NS (0.335)
99 NS (0.715)
3 .057
24 .0001
95 NS (0.461)
77 NS (0.515)
54 NS (0.976)
53 NS (0.455)
0 NS (0.457)
100 NS
74 NS (0.175)
90 NS (0.299)
AD, coronary arterial disease; CT, computed tomography; MOLIERE,
Extracranial Vessels; MRI, magnetic resonance imaging; US, ultrasound.
Table IV. Stroke or death rate after carotid
endarterectomy for patients in participating institutionsa
Variable All, %
Symptomatic,
%
Asymptomatic,
%
Stroke or death
rate 2.1 (12/560) 3.0 (10/333) 0.9 (2/227)
Participating
surgeons 1.7 (7/424) 2.5 (6/236) 0.5 (1/188)
MOLIERE 1.8 (5/279) 3.2 (5/157) 0.0 (0/122)
Not enrolled 1.4 (2/145) 1.3 (1/79) 1.5 (1/66)
Nonparticipating
surgeons 3.7 (5/136) 4.1 (4/97) 2.6 (1/39)
MOLIERE, Modification of Outcomes by Lowering Ischemic Events after
Reconstruction of Extracranial Vessels.
aStroke and death rates after carotid endarterectomy for patients treated by
nonparticipating surgeons were higher but were not statistically different
than the rates for patients treated by participating surgeons.aract
c (n 
14
35
29
22
9 1
52
76
40
7
22
76
34
99
10
54
97
80
54
50
0.6
100
66
90
raft; Cgeons (mean, 4.7 vs 3.4 days, P  .046). This difference
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patients only.
The mean volume of CEAs per participating institution
was 56.1 procedures (range, 7-113 procedures) during the
12 months of the study. The mean volume per surgeon was
16.5 procedures (range, 2-42; median, 15.5 procedures).
Of the 34 surgeons in participating institutions, 10 had a
volume of 10 CEAs and nine had a volume of 20. We
could not demonstrate a relation between surgeon volume
Table V. Thirty-day complication rates and postoperative
participating and nonparticipating surgeons
Variable Participating surgeons (n 
Stroke or death rate
All patients 1.7 (7/424)
Asymptomatic 0.5 (1/188)
Symptomatic 2.5 (6/236)
Mortality rate
All patients 0.7 (3/424)
Asymptomatic 0.5 (1/188)
Symptomatic 0.8 (2/236)
Stroke rate
All patients 1.2 (5/424)
Asymptomatic 0 (0/188)
Symptomatic 2.1 (5/236)
Cardiac complication rate
Overall 7.1 (30/424)
Acute coronary syndrome 2.8 (12/424)
Pulmonary edema 2.4 (10/424)
Arrhythmia 4.0 (17/424)
Reintervention 1.4 (6/424)
Post-op length of stay, days
All patients, mean 3.4
All patients, median 2.0
Symptomatic patients, mean 3.5
Asymptomatic patients, mean 3.2
Fig 1. Comparison of 30-day stroke or death rates, mortality
rates, and stroke rates after carotid endarterectomy between par-
ticipating (white bars) and nonparticipating (black bars) surgeons
for all patients, symptomatic patients, and asymptomatic patients.
There was a trend toward higher stroke rates after carotid endar-
terectomy performed by nonparticipating surgeons. The P value
for each comparison is shown.or center volume and SDRs.DISCUSSION
Many experts have called for independent audits of the
outcomes of carotid surgery to ensure that the results from
landmark trials are translated into effective clinical prac-
tice.7 The concept behind MOLIERE is that surgeon and
neurologist involvement in a prospective manner is a pre-
requisite for them to evaluate, compare, and improve their
practice.8 The finding of this study was that such an online
prospective registry was as feasible for CEA as it is for other
stroke prevention treatment.9 Participating surgeons spent
2 minutes online to enter patient data and were provided
with accurate data on their SDRs. The surgeons and neu-
rologist in each participating institution were at the heart of
the process to evaluate and improve CEA results.
Several surgeons from the province of Quebec have
participated in the two major North American randomized
clinical trials on CEA.1,2 Many of them have also re-
examined their own results by means of retrospective stud-
ies.10,11 Nault et al12 showed that the rate of CEAs in
Quebec was similar to that in Ontario during the 1990s,12
but no province-wide audit of outcomes and appropriate-
ness has been performed. Because the benefit of CEA also
depends on how the results of these clinical trials (defining
the efficacy) are applied to actual clinical practice (the
effectiveness of the procedure), the effectiveness of CEA in
Quebec has not been demonstrated.13
It is with this understanding of the challenges created
by evaluating effectiveness that we established, what is to
our knowledge, the first Canadian online prospective study
of CEAs involving community surgeons as well as surgeons
from larger academic centers. The major advantage of our
th of stay after carotid endarterectomy performed by
), % Nonparticipating surgeons (n  136), % P
3.7 (5/136) .16
2.6 (1/39) .22
4.1 (4/97) .44
0.7 (1/136) 1.0
0 (0/39) .65
1.0 (1/97) .87
3.7 (5/136) .056
2.6 (1/39) .03
4.1 (4/97) .31
8.8 (12/136) .50
2.2 (3/136) .79
5.9 (8/136) .04
2.2 (3/136) .32
2.9 (4/136) .24
4.7 .046
2.0
5.4 .035
3.0 .72leng
424methodology is that it places surgeons at the center of the
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re-evaluation. Another advantage is that it enables the
inclusion of remote locations in effectiveness research. On-
line databases have the advantage of being much less oner-
ous and costly than conventional prospective studies: after
the procedure, the surgeons spend about 2 minutes to
enter the data for each category. Moreover, because the
process is paperless, surgeons can access the database at
different locations, at their leisure, 24 hours a day, 7 days a
week, to complete their data entry in an efficient manner.
We could not evaluate the province-wide effectiveness
of MOLIERE because participation among institutions
and surgeons performing CEA was lower than anticipated.
The number of patients enrolled in MOLIERE was also
Fig 2. A, Overall stroke or death rates per surgeon participation
in Modification of Outcomes by Lowering Ischemic Events after
Reconstruction of Extracranial Vessels (MOLIERE). Each dot
represents a surgeon. The three surgeons with the highest SDRs
(black arrow) had low patient enrollment. All surgeons had overall,
symptomatic, and asymptomatic SDRs within accepted standards.
One nonparticipating surgeon had an overall SDR of 10% with
95% confidence interval (CI) within accepted standards.B,Overall
stroke or death rates per center participation in MOLIERE. Each
dot represents a participating center. The center with the highest
SDRs (black arrow) was also the center with the lowest patient
inclusion rate in MOLIERE. Volume (n) per center is also de-
picted.lowered by a 65% inclusion rate by participating surgeons.Only a few surgeons were able to enroll all of their patients
in MOLIERE. A government administrative database al-
lowed us to determine that the number of CEAs during the
12months ofMOLIEREwas nearly 1200. Thus, voluntary
participation in this first project enrolled25% of patients.
In future projects, it should be possible to address most of
the reasons stated by the surgeons for their lack of partici-
pation.
This study has shown that sharing confidential infor-
mation on the Internet can be done in a fast, reliable, and
secure way, surgeons who participated in MOLIERE dem-
onstrated adequate SDRs, and our audit was able to vali-
date this method of data entry. Research Ethics Board
approval was only necessary for this first study because
external audits were required to access all CEA-linked
hospital data. It will no longer be required in subsequent
projects, and obtaining consent has been proven to be
limiting factor in creating a registry.14 The validity of future
projects would be better ensured by a multidisciplinary
approach for data entry by a dedicated nurse, physician, or
referring neurologist. This should also have an effect on
compliance, because referring neurologists have a signifi-
cant interest in demonstrating the usefulness of these inter-
ventions. In the future, to ensure complete data entry,
neurologists could only refer patients to surgeons who
agree to enter the patient information in the databank
before CEA. In addition, vascular surgery societies could
take the leadership of such projects, or hospital privileges
could be pending on the surgeons participation.
Most important, MOLIERE demonstrated that sur-
geons had adequate SDRs. In the past, improved CEA
outcomes have been correlated with high surgeon volume
and high hospital volume as well as surgeons specializing in
vascular surgery.15-20 Despite this, we believe that surgeons
interested in their own surgery outcomes are an important
confounding factor, as has been reported previously.11,21
Although nonparticipating surgeons had adequate SDRs,
the fact that there was a trend toward higher stroke rate in
that group and that the centers and surgeons with the
highest SDRs were also those who had a low participa-
tion in MOLIERE could be seen as an argument for
MOLIERE. MOLIERE is a way to insure quality of care
by identifying suboptimal results to improve them. For
this reason, the scientific societies and the quality insurance
body in each hospital should stimulate interest for future
similar projects and increase hospital and surgeon partici-
pation.
Complication rates could be underestimated when
surgeons are the only ones evaluating their results. The
integration of a multidisciplinary approach, including a
neurologist, would allow more accurate estimation of com-
plications. However, our validation process did not reveal
any strokes that were missed during MOLIERE.
CONCLUSION
Van Der Fleuten22 defined five criteria for determining
the usefulness of a particular method of assessment: reliabil-
ity, validity, impact on future learning, acceptability to
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concept that meets all of these criteria and should be used
to improve the quality of care of patients undergoing CEA.
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